Infections in immunosuppressed travellers with autoimmune inflammatory diseases-a narrative review and advice for clinical practice.

Abstract

The management of autoimmune, inflammatory diseases has been revolutionized by biologic therapies. A beneficial consequence of better disease control is that more patients are well enough to travel the world. There is now a class of traveller, the significantly immunosuppressed person with autoimmune disease, with specific risks and requirements. This review introduces the concept of the pre-travel risk assessment and discusses the major vaccine-preventable and non-vaccine-preventable travel-associated infections. The challenges and controversies around vaccination and immunosuppression are reviewed with advice for clinical practice.

• Authors: Victoria Allen, Nicky Longley
• Journal: Rheumatology (Oxford, England) (Rheumatology (Oxford)) Vol. 60 Issue 9 Pg. 3969-3976 (09 01 2021) ISSN: 1462-0332 [Electronic] England
• PMID: 34022043 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
• Copyright: © The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.

Topics

• Autoimmune Diseases (immunology)
• Communicable Disease Control
• Humans
• Immunocompromised Host (immunology)
• Risk Assessment
• Travel-Related Illness
• Vaccine-Preventable Diseases (immunology, prevention & control)